E Averbukh, R G Devenyi, W C Lam, A R Berger. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » HumansMacula LuteaMacular Degeneration/complicationsPlasminogen Activators/therapeutic useRetinal Hemorrhage/drug therapyRetinal Hemorrhage/etiologyRetinal Vessels/pathologySulfur Hexafluoride/therapeutic useThrombolytic TherapyTissue Plasminogen Activator/therapeutic useVisual Acuity
Substances: See more » Plasminogen ActivatorsTissue Plasminogen ActivatorSulfur Hexafluoride
Year: 2000 PMID: 11097563 DOI: 10.1016/s0161-6420(00)00295-5
Source DB: PubMed Journal: Ophthalmology ISSN: 0161-6420 Impact factor: 12.079